(Q44018868)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

29 November 2017

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Treatment of diabetic neuropathy and neuropathic pain: how far have we come? (English)

1 reference

29 November 2017

0 references

1 reference

Dan Ziegler

1

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 February 2008

1 reference

29 November 2017

1 reference

29 November 2017

volume

31 Suppl 2

1 reference

29 November 2017

page(s)

S255-61

1 reference

Effective treatment of symptomatic diabetic polyneuropathy by high-frequency external muscle stimulation

29 November 2017

cites work

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DC08-S263

Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DC08-S263

Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DC08-S263

Diabetic somatic neuropathies

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DC08-S263

Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DC08-S263

Algorithm for neuropathic pain treatment: an evidence based proposal.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DC08-S263

Morphine, gabapentin, or their combination for neuropathic pain.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DC08-S263

Diabetic neuropathies

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DC08-S263

Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DC08-S263

Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DC08-S263

Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double-blind, placebo-controlled studies

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DC08-S263

Consensus and contention in the treatment of chronic nerve-damage pain.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DC08-S263

Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DC08-S263

Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DC08-S263

Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DC08-S263

A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DC08-S263

The effect of monochromatic infrared energy on sensation in patients with diabetic peripheral neuropathy: a double-blind, placebo-controlled study

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DC08-S263

A prospective study of painful symptoms, small-fibre function and peripheral vascular disease in chronic painful diabetic neuropathy

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DC08-S263

Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DC08-S263

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DC08-S263

Impact of disease characteristics on the efficacy of duloxetine in diabetic peripheral neuropathic pain

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DC08-S263

Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DC08-S263

A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DC08-S263

Duloxetine vs. placebo in patients with painful diabetic neuropathy

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DC08-S263

Diabetic neuropathies: a statement by the American Diabetes Association

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DC08-S263

Effectiveness of frequency-modulated electromagnetic neural stimulation in the treatment of painful diabetic neuropathy

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DC08-S263

Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DC08-S263

Mechanisms of disease: mechanism-based classification of neuropathic pain-a critical analysis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DC08-S263

Reversal of diabetic peripheral neuropathy with phototherapy (MIRE) decreases falls and the fear of falling and improves activities of daily living in seniors.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DC08-S263

Risk factors for mortality in Type II (non-insulin-dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR4

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DC08-S263

C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DC08-S263

Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DC08-S263

Showing neuropathy is related to increased mortality in diabetic patients - a survival analysis using an accelerated failure time model

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.2337/DC08-S263

Identifiers

DOI

10.2337/DC08-S263

1 reference

29 November 2017

1 reference